These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Live-imaging of revertant and therapeutically restored dystrophin in the DmdEGFP-mdx mouse model for Duchenne muscular dystrophy. Petkova MV, Stantzou A, Morin A, Petrova O, Morales-Gonzalez S, Seifert F, Bellec-Dyevre J, Manoliu T, Goyenvalle A, Garcia L, Richard I, Laplace-Builhé C, Schuelke M, Amthor H. Neuropathol Appl Neurobiol; 2020 Oct 02; 46(6):602-614. PubMed ID: 32573804 [Abstract] [Full Text] [Related]
17. Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy. Potter RA, Griffin DA, Heller KN, Peterson EL, Clark EK, Mendell JR, Rodino-Klapac LR. Hum Gene Ther; 2021 Apr 02; 32(7-8):375-389. PubMed ID: 33397205 [Abstract] [Full Text] [Related]
18. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle. Lindsay A, Larson AA, Verma M, Ervasti JM, Lowe DA. J Appl Physiol (1985); 2019 Feb 01; 126(2):363-375. PubMed ID: 30571283 [Abstract] [Full Text] [Related]
19. Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin. Albuquerque-Pontes GM, Casalechi HL, Tomazoni SS, Serra AJ, Ferreira CSB, Brito RBO, de Melo BL, Vanin AA, Monteiro KKDS, Dellê H, Frigo L, Marcos RL, de Carvalho PTC, Leal-Junior ECP. Lasers Med Sci; 2018 May 01; 33(4):755-764. PubMed ID: 29209866 [Abstract] [Full Text] [Related]